Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Escalating U.S.-Iran tensions and uncertainty over negotiations are driving attention to DJT, with traders focused on potential military action, Strait of Hormuz disruptions, higher energy costs, and broader inflation and economic risk. Supporters view Trumps foreign-policy moves as strengthening U.S. security, while critics argue the conflict, rising fuel costs, and media restrictions are damaging the economy and his political standing.

Traders are linking NEARs sharp rally to the launch of confidential perpetual contracts powered by Hyperliquid, with privacy-focused leveraged trading emerging as the immediate catalyst. The move has strengthened bullish discussion around NEARs AI, agent and cross-chain infrastructure, though some traders view the surge as momentum- or liquidity-driven and warn of a pullback.

Uranium Energy is drawing attention after its fiscal Q3 update showed production ramping but no uranium sales, prompting concerns about near-term revenue, operating costs and valuation. Traders remain divided, with bears focused on execution and dilution risk while bulls point to the companys cash-rich, debt-free balance sheet, unhedged inventory and longer-term U.S. nuclear-fuel demand.

A reported U.S.-Denmark-Greenland security agreement has put CRMLs Tanbreez rare-earth project at the center of renewed critical-minerals speculation, with traders viewing restrictions on Chinese and Russian investment as a strategic tailwind. Bullish participants expect sector momentum and possible short covering, while skeptics note the agreement is not a direct mining, funding, or permitting commitment and does not change the projects development timeline.

ChinaU.S. tensions over rare-earth exports and negotiations are driving attention to MP, alongside continued discussion of its government-backed domestic mine-to-magnet expansion and planned GM magnet deliveries. Traders are divided between a bullish view that supply-chain restrictions and U.S. support strengthen MPs strategic position and concerns that a China deal or broader weakness could pressure the stock in the near term.

Reports of institutional and real-world-asset adoption, particularly NYSE testing Avalanche for a tokenized-securities platform, are driving renewed attention alongside strong volume and broader altcoin rotation. Traders are largely bullish on the momentum and Avalanches tokenization prospects, though others view the move as a speculative pump and remain concerned about weak follow-through and token inflation.

Speculation around a potential POSCO strategic partnership remains the main focus, with traders debating whether a deal will be finalized or abandoned and how it could affect Cleveland-Cliffs valuation and debt position. The discussion is reinforced by improving hot-rolled steel prices, expectations for stronger upcoming results, and elevated short interest, prompting both short-squeeze optimism and skepticism over leverage and profitability.

The discussion remains fragmented, primarily centering on debates regarding the company's valuation, its competitive position against emerging robotic surgery systems, and its role as a high-quality "compounder" in a volatile market. Traders are divided between viewing recent price weakness as a long-term accumulation opportunity and concerns over near-term growth deceleration.

Starknets privacy and BitcoinFi pushparticularly the rollout of strkBTC and STRK20 for shielded Bitcoin and ERC-20 transactionsis driving attention, alongside its post-quantum STARK technology. Traders are bullish on the differentiated infrastructure and growing ecosystem activity, while others remain cautious about token-unlock-related selling pressure and weak price structure.

The proposed Tempus acquisition of Personalis is driving attention, with traders focused on merger approval, exchange-ratio and regulatory risks. Many view the deal as undervaluing Personalisparticularly given its MRD technology and links to Merck/Modernas personalized cancer-vaccine workand are urging a no vote or speculating about a competing bid, while others expect the transaction to close.